Halozyme Withdraws Evotec Bid After Rebuff, Reaffirms Strong Growth Outlook [Yahoo! Finance]
Evotec SE (EVO)
NASDAQ:AMEX Investor Relations:
eatonvance.com
Company Research
Source: Yahoo! Finance
Evotec SE (NASDAQ: EVO ) for 11 euro ($11.44) per share in cash, implying a fully diluted equity value of 2.0 billion euro. This move comes after prolonged efforts to engage with Evotec, which expressed its desire to remain independent, Halozyme said. In addition to this, Halozyme reaffirmed its strong business outlook, with its 2024 guidance signaling continued growth. The company expects revenue between $970 million and $1.02 billion ($1.003 billion) and an adjusted EBITDA range of $595 million to $625 million, reflecting significant double-digit growth. Halozyme is confident in its ability to execute its strategy, with the goal of achieving ten approved products with ENHANZE by 2025 and $1 billion in royalty revenue by 2027. Also Read: US Business Activity Soars To 31-Month Highs In November: Small Caps Rally, Dow Tops 44,000 Helen Torley, CEO of Halozyme, explained that although the merger would have created a leading global pharma services company, Evotec was not open
Show less
Read more
Impact Snapshot
Event Time:
EVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EVO alerts
High impacting Evotec SE news events
Weekly update
A roundup of the hottest topics
EVO
News
- Comment on Withdrawn Non-Binding Offer [Yahoo! Finance]Yahoo! Finance
- Comment on Withdrawn Non-Binding OfferAccesswire
- Halozyme Withdraws Proposal to Acquire Evotec Following Evotec's Unwillingness to Engage in Discussions [Yahoo! Finance]Yahoo! Finance
- Comment on Media Report [Yahoo! Finance]Yahoo! Finance
- Comment on Media ReportAccesswire